Clinical Trial Update: Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting access to nivolumab for adults with selected rare cancer types; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Neoplasm
• Penile Neoplasm
• Renal Cell Carcinoma
• Skin Neoplasm

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: UNICANCER | Conditions: Carcinoma, Renal Cell, Head and Neck Neoplasm | Phase 2 | Status: COMPLETED